Revenue: โน279.4 cr (+28% YoY, +8% QoQ) โ highest ever.
โขEBITDA: โน64.5 cr ; Adjusted EBITDA: โน73.7 cr (26.7% margin).
โขNet Cash: โน369.2 cr; company remains debt-free.
โขNew hospitals (Delhi & Faridabad-20): Causing ~3.3% margin drag; breakeven in 15โ17 months.
โขAgra acquisition: EBITDA positive from day 1; ARPOB >โน30k.
โขTotal beds with Agra: ~2,550; plan to double capacity in 3โ4 years.
โขOccupancy: 66% (despite 700 new beds).
โขARPOB: โน32,015; guided 8โ10% growth p.a.
โขALOS: Improved to 4.06 days.
โขCGHS tariff hike: adds 1.5% revenue & 1% EBITDA in FY26; higher in FY27.
โขGST relief: +30โ50 bps EBITDA.
โขFY26 guidance:
โขRevenue growth โฅ30%
โขMargins stable with upside
โขNew units breakeven in 15โ17 months
Leave a Reply